Polymorphic Basal Rates of Continuous Subcutaneous Insulin Infusion among Taiwanese Children with Type 1 Diabetes
Table 2
Clinical variables before and after continuous subcutaneous insulin infusion (CSII) therapy in all participants.
3 months before
3 months after
1 year later
Last visit
HbA1c (mmol/mol)
67 ± 30
54 ± 17*
54 ± 17*
54 ± 11*
HbA1c (%)
8.3 ± 2.8
7.1 ± 1.5*
7.1 ± 1.0*
7.1 ± 1.0*
Fasting sugar (mmol/L)
9.8 ± 5.6
7.0 ± 2.9*
7.3 ± 3.1*
6.8 ± 2.5*
Triglyceride (mmol/L)
0.94 ± 1.65
0.62 ± 0.27
0.62 ± 0.28
0.55 ± 0.14
Triglyceride (mg/dL, log transformed)
1.79 ± 0.24
1.69 ± 0.13*
1.71 ± 0.16*
1.68 ± 0.11*
Cholesterol (mmol/L)
4.14 ± 0.75
4.06 ± 0.73
4.10 ± 0.71
4.18 ± 0.81
HDL-C (mmol/L)
1.64 ± 0.38
1.56 ± 0.34
1.55 ± 0.32
1.51 ± 0.31
LDL-C (mmol/L)
2.29 ± 0.78
2.33 ± 0.73
2.34 ± 0.72
2.42 ± 0.80
ALT (U/L)
12.1 ± 4.0
12.0 ± 4.1
11.6 ± 4.1
13.8 ± 8.8
Creatinine (μmol/L)
44.0 ± 13.1
45.4 ± 10.7
45.1 ± 11.0
48.6 ± 9.8
SMBG (times/day)
3.8 ± 1.4
6.3 ± 1.6*
4.5 ± 1.4*
4.5 ± 1.4*
Exercise (minutes/week)
89.7 ± 35.6
130.6 ± 58.2*
164.0 ± 82.8*
164.0 ± 82.8*
Data are mean ± standard deviation or percentage. for ANOVA test. *Significant difference () by paired -test as compared to baseline data. SMBG: self-monitoring of blood glucose.
